Rifampin-induced nonresponsiveness of giant cell arteritis to prednisone treatment

Arch Intern Med. 1994 Jul 11;154(13):1521-4.

Abstract

Rifampin is an enzymatic inducer known to increase steroid metabolism. We studied two patients with giant cell arteritis in whom rifampin caused nonresponsiveness to prednisone treatment. A prednisone pharmacokinetics study was done. When rifampin-prednisone treatment must be used in giant cell arteritis, we propose increasing the prednisone dosage to 2 mg/kg per day.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Female
  • Giant Cell Arteritis / drug therapy*
  • Giant Cell Arteritis / metabolism
  • Giant Cell Arteritis / microbiology
  • Humans
  • Prednisone / antagonists & inhibitors
  • Prednisone / pharmacokinetics*
  • Prednisone / therapeutic use
  • Rifampin / pharmacology*
  • Tuberculosis / complications
  • Tuberculosis / drug therapy

Substances

  • Prednisone
  • Rifampin